Atlas Trials

Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance

Clinical trial NCT03933670 · RECRUITING

Trial details

NCT number
NCT03933670
Sponsor
University of California, San Francisco
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate AdenocarcinomaProstate Cancer
Start date
2018-07-18
Primary completion
2027-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.